Cover Image

Second-Generation Cephalosporins-Associated Drug-Induced Liver Disease: A Study in VigiBase with a Focus on the Elderly

Background: The objective of this study was to characterize individual case safety reports (ICSRs) and adverse drug reactions (ADRs) related to second-generation cephalosporins and resulting in hepatobiliary disorders, in VigiBase, WHO global database. Methods: All second-generation cephalosporins h...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mariana Sipos (Author), Andreea Farcas (Author), Daniel Corneliu Leucuta (Author), Camelia Bucsa (Author), Madalina Huruba (Author), Cristina Mogosan (Author)
Format:	Book
Published:	MDPI AG, 2021-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A VigiBase Descriptive Study of Fluoroquinolone-Associated Peripheral Nervous System Disorders
by: Madalina Huruba, et al.
Published: (2022)

A Description of Acute Renal Failure and Nephrolithiasis Associated With Sodium-Glucose Co-Transporter 2 Inhibitor Use: A VigiBase Study
by: Ioana Frent, et al.
Published: (2022)

Prevalence and Risk Factors Associated with Potentially Inappropriate Prescribing According to STOPP-2 Criteria among Discharged Older Patients-An Observational Retrospective Study
by: Mariana Sipos, et al.
Published: (2023)

Infections associated with clozapine: a pharmacovigilance study using VigiBase®
by: Basile Chrétien, et al.
Published: (2023)

The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase®
by: Mafora F. Matlala, et al.
Published: (2023)

Reporting Antimicrobial-Related Adverse Drug Events in Jordan: An Analysis from the VigiBase Database
by: Nizar Mahmoud Mhaidat, et al.
Published: (2023)

Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase
by: Fabrizio Calapai, et al.
Published: (2023)

Risk Factors for Respiratory Depression Associated with Tramadol Based on the Global Pharmacovigilance Database (VigiBase)
by: Sunny Park, et al.
Published: (2024)

Fatal Adverse Events of Dabigatran Combined With Aspirin in Elderly Patients: An Analysis Using Data From VigiBase
by: Qingxia Zhang, et al.
Published: (2021)

Cardiovascular toxicity risk assessment of tyrosine kinase inhibitors: a pharmacovigilance study using the VigiBase database
by: Yusuke Igawa, et al.
Published: (2024)

Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports
by: Janet Sultana, et al.
Published: (2020)

Sexual Dysfunction Induced by Antidepressants-A Pharmacovigilance Study Using Data from VigiBase<sup>TM</sup>
by: Rene Zeiss, et al.
Published: (2024)

PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBase
by: Dahyun Park, et al.
Published: (2024)

Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase<sup>®</sup>)
by: Alemayehu Lelisa Duga, et al.
Published: (2023)

Suspected cutaneous adverse drug reactions reported with traditional medicines: analysis of data for United Nations Asia region from WHO VigiBase
by: Manish J. Barvaliya, et al.
Published: (2023)

Integrase inhibitor drugs during pregnancy and congenital anomalies: A case/non‐case study from the global pharmacovigilance database VigiBase®
by: Laura Saint‐Lary, et al.
Published: (2024)

Myopericarditis Associated with the Novavax COVID-19 Vaccine (NVX-CoV2373): A Retrospective Analysis of Individual Case Safety Reports from VigiBase
by: Diego Macías Saint-Gerons, et al.
Published: (2023)

The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase
by: Vera Battini, et al.
Published: (2023)

The new fifth-generation cephalosporins - a balance between safety and efficacy
by: Aura Rusu, et al.
Published: (2020)

Utilization of psychotropic medicines in Romania during 1998-2018
by: Irina Iaru, et al.
Published: (2023)

Safety of Antibiotics in Hospitalized Children in Romania: A Prospective Observational Study
by: Noémi-Beátrix Bulik, et al.
Published: (2022)

Effectiveness of 3rd generation cephalosporin compare to 3rd generation cephalosporin - macrolides for community acquired pneumonia patients in PKU Muhammadiyah Yogyakarta Hospital
by: Muhammad Dwi Suprobo, et al.
Published: (2019)

The efficacy of third-generation cephalosporin plus metronidazole versus third-generation cephalosporin plus clarithromycin in neonatal outcomes and oxidative stress markers in women with preterm premature rupture of membranes
by: J. W. Kim, et al.
Published: (2020)

ORAL III GENERATION CEPHALOSPORIN CEFTIBUTEN IN TREATMENT OF ACUTE TONSILLOPHARYNGITIS AND OTITIS
by: S. A Karpishchenko, et al.
Published: (2012)

Cephalosporins: A Focus on Side Chains and β-Lactam Cross-Reactivity
by: Saira B. Chaudhry, et al.
Published: (2019)

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
by: Giuseppe Caruso, et al.
Published: (2020)

Kirby-Bauer disc approximation to detect inducible third-generation cephalosporin resistance in <it>Enterobacteriaceae</it>
by: Zhang Bei, et al.
Published: (2004)

Third-Generation Cephalosporin Resistance in Intrinsic Colistin-Resistant Enterobacterales Isolated from Retail Meat
by: Justice Opare Odoi, et al.
Published: (2021)

Novel Siderophore Cephalosporin and Combinations of Cephalosporins with β-Lactamase Inhibitors as an Advancement in Treatment of Ventilator-Associated Pneumonia
by: Szymon Viscardi, et al.
Published: (2024)

Limited impact of a nudge comment in promoting de-escalation to first-generation cephalosporins in urinary tract infections
by: Martin T. Brenneman, et al.
Published: (2022)

Characterization of Third Generation Cephalosporin- and Carbapenem-Resistant <i>Aeromonas</i> Isolates from Municipal and Hospital Wastewater
by: Sara Drk, et al.
Published: (2023)

The control of invasive infection in very low birth weight infants by reduction in the use of 3rd generation cephalosporin
by: Yu Jin Chang, et al.
Published: (2013)

Characteristics of adverse reactions of three anti-glioma drugs in WHO-VigiAccess
by: Huadong Ke, et al.
Published: (2024)

Efficacy and safety of broad spectrum penicillin with or without beta-lactamase inhibitors vs first and second generation cephalosporins as prophylactic antibiotics during cesarean section: a systematic review and meta-analysis
by: Qianqian Song, et al.
Published: (2023)

Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes
by: Yaron Ilan
Published: (2020)

Cephalosporin-induced biliary sludge in children
by: A.E. Abaturov, et al.
Published: (2017)

Cephalosporin-associated biliary pseudolithiasis in children
by: A.E. Abaturov, et al.
Published: (2017)

The Second Generation
by: Phillips, David Graham, 1867-1911

Impact of targeted intervention using a collaborative approach for oral third-generation cephalosporins: An interrupted time-series analysis
by: Ryo Yamaguchi, et al.
Published: (2022)

The Emergence of <i>Klebsiella pneumoniae</i> with Reduced Susceptibility against Third Generation Cephalosporins and Carbapenems in Lagos Hospitals, Nigeria
by: Kabiru O. Akinyemi, et al.
Published: (2021)